With interest rates at record lows and likely to remain there for some time to come, I continue to believe the share market is the best place to put your money.
But where should you invest your funds? Here are two top ASX 200 shares I would invest $5,000 into right now:
CSL Limited (ASX: CSL)
The first ASX 200 share to consider buying with $5,000 is this biotherapeutics company. I believe a recent pullback in its share price has created a buying opportunity for investors. Especially those that are interested in making a long term investment. This share price weakness has been driven by concerns over its plasma collections during the pandemic and the impact this might have on future immunoglobulin and albumin production.
While this is certainly a risk to consider, I’m optimistic that collections will accelerate once the crisis passes. Especially given the higher unemployment levels, which traditionally leads to higher donations. Another positive is that the pandemic is expected to lead to a sharp increase in demand for flu vaccines in the near term. This increase in demand could offset any weakness experienced with immunoglobulin and albumin sales in FY 2021. Outside this, I believe CSL’s pipeline of lucrative therapies have the potential to drive significant sales and profit growth over the next decade. Overall, I think this makes CSL one of the best buy and hold options on the ASX 200 today.
Xero Limited (ASX: XRO)
Another ASX 200 share to consider buying is cloud-based business and accounting software provider Xero. It has really caught the eye in recent years thanks to its stellar recurring revenue growth and the emergence of its operating leverage. This was on display for all to see in FY 2020 when Xero delivered a 29% lift in annualised monthly recurring revenue (AMRR) to NZ$820.6 million and a 52% increase in EBITDA to NZ$139.17 million.
The key drivers of this have been strong growth in subscription numbers, its high retention rate, and a modest increase in average revenue per user. In respect to the former, Xero added 467,000 net subscribers during the 12 months to finish the period at 2.285 million. And while this is a large number, the company estimates that less than 20% of the global English-speaking target market is using cloud-based accounting software at present. Given how superior this type of software is to Excel spreadsheets and notebooks, I expect more businesses to shift to the technology in the coming years. I believe this will support solid subscription and sales growth over the next decade.
And if you have some funds leftover, the five recommendations below look like potential market beaters...
5 stocks under $5
We hear it over and over from investors, "I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I'd be sitting on a gold mine!" And it's true.
And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!
*Extreme Opportunities returns as of June 5th 2020
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and Xero. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- Would Warren Buffett buy a2 Milk Company shares? – August 9, 2020 12:00pm
- Why ResMed shares could be a fantastic buy and hold option – August 9, 2020 11:12am
- Cash rate on hold until after 2022? Buy these ASX dividend shares – August 9, 2020 10:59am